Amyloid fibrils from the viewpoint of protein folding

Cellular and Molecular Life Sciences

Volumn 61, Issue 5, 2004, Pages 511-524

  Ohnishi, S ^a   Takano, K ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Aggregation; Amyloid fibrils; Denatured states; Protein folding

Indexed keywords

AMINO ACID; AMYLOID; ASPARAGINE; BETA 2 MICROGLOBULIN; DEUTERIUM; GLUTAMINE; HYDROGEN; LYSOZYME; PRION PROTEIN; PROTEIN; TTR PROTEIN; UNCLASSIFIED DRUG;

CRYSTAL STRUCTURE; HUMAN; HYDROPHOBICITY; MODEL; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE; PEPTIDE ANALYSIS; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS;

AMYLOID; BETA 2-MICROGLOBULIN; HUMANS; MURAMIDASE; MUTATION; PRIONS; PROTEIN FOLDING;

EID: 1642417648     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3264-8     Document Type: Review

References (171)

1. Chan H. S. and Dill K. A. (1998) Protein folding in the landscape perspective: chevron plots and non-Arrhenius kinetics. Proteins 30: 2-33
2. Dill K. A. and Chan H. S. (1997) From Levinthal to pathways to funnels. Nat. Struct. Biol. 4: 10-19
3. Kelly J. W. (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8: 101-106
4. Prusiner S. B. (1991) Molecular biology of prion diseases. Science 252: 1515-1522
5. Alper T., Cramp W. A., Haig D. A. and Clarke M. C. (1967) Does the agent of scrapie replicate without nucleic acid? Nature 214: 764-766
6. Griffith J. S. (1967) Self-replication and scrapie. Nature 215: 1043-1044
7. Prusiner S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144
8. Glenner G. G., Ein D., Eanes E. D., Bladen H. A., Terry W. and Page D. L. (1971) Creation of 'amyloid' fibrils from Bence Jones proteins in vitro. Science 174: 712-714
9. Connors L. H., Shirahama T., Skinner M., Fenves A. and Cohen A. S. (1985) In vitro formation of amyloid fibrils from intact beta 2-microglobulin. Biochem. Biophys. Res. Commun. 131: 1063-1068
10. Kedar I., Ravid M. and Sohar E. (1976) In vitro synthesis of 'amyloid' fibrils from insulin, calcitonin and parathormone. Isr. J. Med. Sci. 12: 1137-1140
11. Gustavsson A., Engstrom U. and Westermark P. (1991) Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro. Biochem. Biophys. Res. Commun. 175: 1159-1164
12. Kirschner D. A., Inouye H., Duffy L. K., Sinclair A., Lind M. and Selkoe D. J. (1987) Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 84: 6953-6957
13. Castano E. M., Ghiso J., Prelli F., Gorevic P. D., Migheli A. and Frangione B. (1986) In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein. Biochem. Biophys. Res. Commun. 141: 782-789
14. Selvaggini C., De Gioia L., Cantu L., Ghibaudi E., Diomede L., Passerini F. et al. (1993) Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194: 1380-1386
15. Colon W. and Kelly J. W. (1992) Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31: 8654-8660
16. Guijarro J. I., Sunde M., Jones J. A., Campbell I. D. and Dobson C. M. ( 1998) Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. USA 95: 4224-4228
17. Gross M., Wilkins D. K., Pitkeathly M. C., Chung E. W., Higham C., Clark A. et al. (1999) Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB. Protein Sci. 8: 1350-1357
18. Krebs M. R., Wilkins D. K., Chung E. W., Pitkeathly M. C., Chamberlain A. K., Zurdo J. et al. (2000) Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J. Mol. Biol. 300: 541-549
19. Fandrich M., Fletcher M. A. and Dobson C. M. (2001) Amyloid fibrils from muscle myoglobin. Nature 410: 165-166
20. Pertinhez T. A., Bouchard M., Tomlinson E. J., Wain R., Ferguson S. J., Dobson C. M. et al. (2001) Amyloid fibril formation by a helical cytochrome. FEBS Lett. 495: 184-186
21. Divry P. and Florkin M. ( 1927) Sur les propriétés optiques de l'amyloide. C. R. Soc. Biol. 97: 1808-1810
22. Klunk W. E., Jacob R. F. and Mason RP. (1999) Quantifying amyloid by congo red spectral shift assay. Methods Enzymol. 309: 285-305
23. LeVine H. 3rd (1993). Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2: 404-410
24. Naiki H., Higuchi K., Hosokawa M. and Takeda T. (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal. Biochem. 177: 244-249
25. Khurana R., Uversky V. N., Nielsen L. and Fink A. L. (2001) Is Congo red an amyloid-specific dye? J. Biol. Chem. 276: 22715-22721
26. Cohen A. S. and Calkins E. (1959) Electron microscopic observation on a fibrous component in amyloid of diverse origins. Nature 183: 1202-1203
27. Cohen A., Shirahama T. and Skinner M. (1982) Electron Microscopy of Amyloid, Academic Press, New York
28. Eanes E. D. and Glenner G. G. (1968) X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16: 673-677
29. Bonar L., Cohen A. S. and Skinner M. M. (1969) Characterization of the amyloid fibril as a cross-beta protein. Proc. Soc. Exp. Biol. Med. 131: 1373-1375
30. Pauling L. and Corey R. (1951) Configuration of polypeptide chains with favoured orientation around single bonds: two new pleated sheets. Proc. Natl. Acad. Sci. USA 37: 729-739
31. Sunde M., Serpell L. C., Bartlam M., Fraser P. E., Pepys M. B. and Blake C. C. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273: 729-739
32. O'Leary T. J. and Levin I. W. (1985) Secondary structure of endocrine amyloid: infrared spectroscopy of medullary carcinoma of the thyroid. Lab. Invest. 53: 240-242
33. Cascio M., Glazer P. A. and Wallace B. A. (1989) The secondary structure of human amyloid deposits as determined by circular dichroism spectroscopy. Biochem. Biophys. Res. Commun. 162: 1162-1166
34. Jarrett J. T. and Lansbury P. T. Jr (1992) Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31: 12345-12352
35. Lomakin A., Chung D. S., Benedek G. B., Kirschner D. A. and Teplow D. B. (1996) On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. USA 93: 1125-1129
36. Lomakin A., Teplow D. B., Kirschner D. A. and Benedek G. B. (1997) Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc. Natl. Acad. Sci. USA 94: 7942-7947
37. Han H., Weinreb P. H. and Lansbury P. T. Jr (1995) The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. 2: 163-169
38. Ohnishi S., Koide A. and Koide S. (2000) Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet. J. Mol. Biol. 301: 477-489
39. Wood S. J., Wypych J., Steavenson S., Louis J. C., Citron, M. and Biere A. L. (1999) alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J. Biol. Chem. 274: 19509-19512
40. Nordstedt C., Naslund J., Tjernberg L. O., Karlstrom, A. R., Thyberg J. and Terenius L. (1994) The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils. J. Biol. Chem. 269: 30773-30776
41. Blake C. C., Geisow M. J., Oatley S. J., Rerat B. and Rerat C. (1978) Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J. Mol. Biol. 121: 339-356
42. Lai Z., Colon W. and Kelly J. W. (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35: 6470-6482
43. Westermark P., Sletten K., Johansson B. and Cornwell G. G. 3rd (1990) Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. USA 87: 2843-2845
44. Saraiva M. J. (1995) Transthyretin mutations in health and disease. Hum. Mutat. 5: 191-196
45. McCutchen S. L., Colon W. and Kelly J. W. (1993) Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 32: 12119-12127
46. Lai Z., McCulloch J., Lashuel H. A. and Kelly J. W. (1997) Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. Biochemistry 36: 10230-10239
47. Hammarstrom P., Jiang X., Deechongkit S. and Kelly J. W. (2001) Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy. Biochemistry 40: 11453-11459
48. Hammarstrom P., Schneider F. and Kelly J. W. (2001) Trans-suppression of misfolding in an amyloid disease. Science 293: 2459-2462
49. Hammarstrom P., Wiseman R. L., Powers E. T. and Kelly J. W. (2003) Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299: 713-716
50. Liu K., Cho H. S., Lashuel H. A., Kelly J. W. and Wemmer D. E. (2000) A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat. Struct. Biol. 7: 754-757
51. Liu K., Kelly J. W. and Wemmer D. E. (2002) Native state hydrogen exchange study of suppressor and pathogenic variants of transthyretin. J. Mol. Biol. 320: 821-832
52. Pepys M. B., Hawkins P. N., Booth D. R., Vigushin D. M., Tennent G. A., Soutar, A. K. et al. (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362: 553-557
53. Gillmore J. D., Booth D. R., Madhoo S., Pepys M. B. and Hawkins P. N. (1999) Hereditary renal amyloidosis associated with variant lysozyme in a large English family. Nephrol. Dial. Transplant. 14: 2639-2644
54. Valleix S., Drunat S., Philit J. B., Adoue D., Piette J. C., Droz D. et al. (2002) Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int. 61: 907-912
55. Yazaki M., Farrell S. A. and Benson M. D. (2003) A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. Kidney Int. 63: 1652-1657
56. Funahashi J., Takano K., Ogasahara K., Yamagata Y. and Yutani K. (1996) The structure, stability and folding process of amyloidogenic mutant human lysozyme. J. Biochem. 120: 1216-1223
57. Booth D. R., Sunde M., Bellotti V., Robinson C. V., Hutchinson W. L., Fraser P. E. et al. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385: 787-793
58. Canet D., Sunde M., Last A. M., Miranker A., Spencer A., Robinson C. V. et al. (1999) Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants. Biochemistry 38: 6419-6427
59. Takano K., Funahashi J. and Yutani K. (2001) The stability and folding process of amyloidogenic mutant human lysozymes. Eur. J. Biochem. 268: 155-159
60. Chamberlain A. K., Receveur V., Spencer A., Redfield C. and Dobson C. M. (2001) Characterization of the structure and dynamics of amyloidogenic variants of human lysozyme by NMR spectroscopy. Protein Sci. 10: 2525-2530
61. Morozova-Roche L. A., Zurdo J., Spencer A., Noppe W., Receveur V., Archer D. B. et al. (2000) Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J. Struct. Biol. 130: 339-351
62. Canet D., Last A. M., Tito P., Sunde M., Spencer A., Archer D. B. et al. (2002) Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat. Struct. Biol. 9: 308-315
63. Goda S., Takano K., Yamagata Y., Maki S., Namba K. and Yutani K. (2002) Elongation in a beta-structure promotes amyloid-like fibril formation of human lysozyme. J. Biochem. (Tokyo) 132: 655-661
64. Esposito G., Garcia J., Mangione P., Giorgetti S., Corazza A., Viglino P. et al. (2003) Structural and folding dynamics properties of T70N variant of human lysozyme. J. Biol. Chem. 22: 22
65. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L. and Wiley D. C. (1987) Structure of the human class I histocompatibiliry antigen, HLA-A2. Nature 329: 506-512
66. Floege J. and Ehlerding G. ( 1996) Beta-2-microglobulin-associated amyloidosis. Nephron 72: 9-26
67. Esposito G., Michelutti R., Verdone G., Viglino P., Hernandez H., Robinson C. V. et al. (2000) Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci. 9: 831-845
68. Kozhukh G. V., Hagihara Y., Kawakami T., Hasegawa K., Naiki H. and Goto Y. (2002) Investigation of a peptide responsible for amyloid fibril formation of beta 2-microglobulin by achromobacter protease I. J. Biol. Chem. 277: 1310-1315
69. Hasegawa K., Ohhashi Y., Yamaguchi I., Takahashi N., Tsutsumi S., Goto Y. et al. (2003) Amyloidogenic synthetic peptides of beta2-microglobulin-a role of the disulfide bond. Biochem. Biophys. Res. Commun. 304: 101-106
70. Kad N. M., Thomson N. H., Smith D. P., Smith D. A. and Radford S. E. (2001) Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J. Mol. Biol. 313: 559-571
71. McParland V. J., Kad N. M., Kalverda A. P., Brown A., Kirwin-Jones P., Hunter M. G. et al. (2000) Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. Biochemistry 39: 8735-8746
72. Morgan C. J., Gelfand M., Atreya C. and Miranker A. D. (2001) Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation. J. Mol. Biol. 309: 339-345
73. Eakin C. M., Knight J. D., Morgan C. J., Gelfand M. A. and Miranker A. D. (2002) Formation of a copper specific binding site in non-native states of beta-2-microglobulin. Biochemistry 41: 10646-10656
74. Verdone G., Corazza A., Viglino P., Pettirossi F., Giorgetti S., Mangione P. et al. (2002) The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition. Protein Sci. 11: 487-499
75. Hoshino M., Katou H., Hagihara Y., Hasegawa K., Naiki H. and Goto Y. (2002) Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nat. Struct. Biol. 9: 332-336
76. McParland V. J., Kalverda A. P., Homans S. W. and Radford S. E. (2002) Structural properties of an amyloid precursor of beta(2)-microglobulin. Nat. Struct. Biol. 9: 326-331
77. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J. L., Lehmann S., Launay J. M. et al. (2000) Signal transduction through prion protein. Science 289: 1925-1928
78. Burns C. S., Aronoff-Spencer E., Dunham C. M., Lario P., Avdievich N. I., Antholine W. E. et al. (2002) Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry 41: 3991-4001
79. Wickner R. B. (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264: 566-569
80. Wickner R. B., Taylor K. L., Edskes H. K., Maddelein M. L., Moriyama H. and Roberts B. T. (2000) Prions of yeast as heritable amyloidoses. J. Struct. Biol. 130: 310-322
81. Serio T. R. and Lindquist S. L. (2000) Protein-only inheritance in yeast: something to get [PSI+]-ched about. Trends Cell Biol. 10: 98-105
82. Masison D. C. and Wickner R. B. (1995) Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270: 93-95
83. DePace A. H., Santoso A., Hillner P. and Weissman J. S. (1998) A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93: 1241-1252
84. Michelitsch M. D. and Weissman J. S. (2000) A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc. Natl. Acad. Sci. USA 97: 11910-11915
85. Pan K. M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D. et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90: 10962-10966
86. Caughey B. (2001) Interactions between prion protein isoforms: the kiss of death? Trends Biochem. Sci. 26: 235-242
87. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R. and Wuthrich K. (1996) NMR structure of the mouse prion protein domain PrP(121-321). Nature 382: 180-182
88. James T. L., Liu H., Ulyanov N. B., Fair-Jones S., Zhang H., Donne D. G. et al. (1997) Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 94: 10086-10091
89. Hosszu L. L., Baxter N. J., Jackson G. S., Power A., Clarke A. R., Waltho J. P. et al. (1999) Structural mobility of the human prion protein probed by backbone hydrogen exchange. Nat. Struct. Biol. 6: 740-743
90. Wildegger G., Liemann S. and Glockshuber R. (1999) Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates. Nat. Struct. Biol. 6: 550-553
91. Liemann S. and Glockshuber R. (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38: 3258-3267
92. Swietnicki W., Petersen R., Gambetti P. and Surewicz W. K. (1997) pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J. Biol. Chem. 272: 27517-27520
93. Hornemann S. and Glockshuber R. (1998) A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. Proc. Natl. Acad. Sci. USA 95: 6010-6014
94. Jackson G. S., Hill A. F., Joseph C., Hosszu L., Power A., Waltho J. P. et al. (1999) Multiple folding pathways for heterologously expressed human prion protein. Biochim. Biophys. Acta 1431: 1-13
95. Tjernberg L. O., Naslund J., Lindqvist F., Johansson J., Karlstrom A. R., Thyberg J. et al. (1996) Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271: 8545-8548
96. Kheterpal I., Zhou S., Cook K. D. and Wetzel R. (2000) Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange. Proc. Natl. Acad. Sci. USA 97: 13597-13601
97. Mazor Y., Gilead S., Benhar I. and Gazit E. (2002) Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J. Mol. Biol. 322: 1013-1024
98. Antzutkin O. N., Balbach J. J., Leapman R. D., Rizzo N. W., Reed J. and Tycko R. (2000) Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. Proc. Natl. Acad. Sci. USA 97: 13045-13050
99. Balbach J. J., Ishii Y., Antzutkin O. N., Leapman R. D., Rizzo N. W., Dyda F. et al. (2000) Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39: 13748-13759
100. Petkova A. T., Ishii Y., Balbach J. J., Antzutkin O. N., Leapman R. D., Delaglio F. et al. (2002) A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA 99: 16742-16747
101. Schormann N., Murrell J. R., Liepnieks J. J. and Benson M. D. (1995) Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formation. Proc. Natl. Acad. Sci. USA 92: 9490-9494
102. Maury C. P., Alli K. and Baumann M. (1990) Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline. FEBS Lett. 260: 85-87
103. Kelly J. W. (2000) Mechanisms of amyloidogenesis. Nat. Struct. Biol. 7: 824-826
104. Serio T. R., Cashikar A. G., Kowal A. S., Sawicki G. J., Moslehi J. J., Serpell L. et al. (2000) Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289: 1317-1321
105. Soto C. (2001). Protein misfolding and disease; protein refolding and therapy. FEBS Lett. 498: 204-207
106. Souillac P. O., Uversky V. N., Millett I. S., Khurana R., Doniach S. and Fink A. L. (2002) Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation. Evidence for an off-pathway oligomer at acidic pH. J. Biol. Chem. 277: 12666-12679
107. Pallitto M. M. and Murphy R. M. (2001) A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys. J. 81: 1805-1822
108. Yonezawa Y., Tanaka S., Kubota T., Wakabayashi K.,Yutani K. and Fujiwara S. (2002) An insight into the pathway of the amyloid fibril formation of hen egg white lysozyme obtained from a small-angle X-ray and neutron scattering study. J. Mol. Biol. 323: 237-251
109. Kayed R., Head E., Thompson J. L., Mclntire T. M., Milton S. C., Cotman C. W. et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489
110. Perutz M. (1994) Polar zippers: their role in human disease. Protein Sci. 3: 1629-1637
111. Perutz M. F., Johnson T., Suzuki M. and Finch J. T. (1994) Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 91: 5355-5358
112. Orpiszewski J. and Benson M. D. (1999) Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation. J. Mol. Biol. 289: 413-428
113. Blondelle S. E., Forood B., Houghten R. A. and Perez-Paya E. (1997) Polyalanine-based peptides as models for self-associated beta-pleated-sheet complexes. Biochemistry 36: 8393-8400
114. Liu Y. and Eisenberg D. (2002) 3D domain swapping: as domains continue to swap. Protein Sci. 11: 1285-1299
115. Schlunegger M. P., Bennett M. J. and Eisenberg D. (1997) Oligomer formation by 3D domain swapping: a model for protein assembly and misassembly. Adv. Protein Chem. 50: 61-122
116. Knaus K. J., Morillas M., Swietnicki W., Malone M., Surewicz W. K. and Yee V. C. (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8: 770-774
117. Janowski R., Kozak M., Jankowska E., Grzonka Z., Grubb A., Abrahamson M. et al. (2001) Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat. Struct. Biol. 8: 316-320
118. Staniforth R. A., Giannini S., Higgins L. D., Conroy M. J., Hounslow A. M., Jerala R. et al. (2001) Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J. 20: 4774-4781
119. Rousseau F., Schymkowitz J. W., Wilkinson H. R. and Itzhaki L. S. (2001) Three-dimensional domain swapping in p13suc1 occurs in the unfolded state and is controlled by conserved proline residues. Proc. Natl. Acad. Sci. USA 98: 5596-5601
120. Liu Y., Gotte G., Libonati M. and Eisenberg D. (2001) A domain-swapped RNase A dimer with implications for amyloid formation. Nat. Struct. Biol. 8: 211-214
121. MacPhee C. E. and Dobson C. M. (2000) Chemical dissection and reassembly of amyloid fibrils formed by a peptide fragment of transthyretin. J. Mol. Biol. 297: 1203-1215
122. Tjernberg L. O., Callaway D. J., Tjernberg A., Hahne S., Lilliehook C., Terenius L. et al. (1999) A molecular model of Alzheimer amyloid beta-peptide fibril formation. J. Biol. Chem. 274: 12619-12625
123. Tenidis K., Waldner M., Bernhagen J., Fischle W., Bergmann M., Weber M. et al. (2000) Identification of a penta-and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J. Mol. Biol. 295: 1055-1071
124. Nilsson M. R. and Raleigh D. P. (1999) Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. J. Mol. Biol. 294: 1375-1385
125. Richardson J. S. and Richardson D. C. (2002) Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. USA 99: 2754-2759
126. Moriarty D. F. and Raleigh D. P. (1999) Effects of sequential proline substitutions on amyloid formation by human amylin20-29. Biochemistry 38: 1811-1818
127. Wang W. and Hecht M. H. (2002) Rationally designed mutations convert de novo amyloid-like fibrils into monomeric beta-sheet proteins. Proc. Natl. Acad. Sci. USA 99: 2760-2765
128. Jaroniec C. P., MacPhee C. E., Astrof N. S., Dobson C. M. and Griffin R. G. (2002) Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril. Proc. Natl. Acad. Sci. USA 99: 16748-16753
129. Jaikaran E. T., Higham C. E., Serpell L. C., Zurdo J., Gross M., Clark A. et al. (2001) Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J. Mol. Biol. 308: 515-525
130. Perutz M. F., Finch J. T., Berriman J. and Lesk A. (2002) Amyloid fibers are water-filled nanotubes. Proc. Natl. Acad. Sci. USA 99: 5591-5595
131. Balbirnie M., Grothe R. and Eisenberg D. S. (2001) An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid. Proc. Natl. Acad. Sci. USA 98: 2375-2380
132. Marsh R. E., Corey R. B. and Pauling L. (1955) An investigation of the structure of silk fibroin. Biochim. Biophys. Acta 16: 1-34
133. Fandrich M. and Dobson C. M. (2002) The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J. 21: 5682-5690
134. Lotz B. (1974) Crystal structure of polyglycine I. J. Mol. Biol. 87: 169-180
135. Inestrosa N. C., Alvarez A., Perez C. A., Moreno R. D., Vicente M., Linker C. et al. (1996) Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16: 881-891
136. Naiki H., Hasegawa K., Yamaguchi I., Nakamura H., Gejyo F. and Nakakuki K. (1998) Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 37: 17882-17889
137. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F. et al. (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91: 3270-3274
138. Konno T. (2001) Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril. Biochemistry 40: 2148-2154
139. Oberg K., Chrunyk B. A., Wetzel R. and Fink A. L. (1994) Nativelike secondary structure in interleukin1 beta inclusion bodies by attenuated total reflectance FTIR. Biochemistry 33: 2628-2634
140. Fink A. L. (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des. 3: R9-R23
141. Khurana R., Gillespie J. R., Talapatra A., Minert L. J., Ionescu-Zanetti C., Millett I. et al. (2001) Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40: 3525-3535
142. Clark A. H., Saunderson D. H. and Suggett A. (1981) Infrared and laser-Raman spectroscopic studies of thermally-induced globular protein gels. Int. J. Pept. Protein Res. 17: 353-364
143. Kato A. and Takagi T. (1988) Formation of intermolecular beta-sheet structure during heat denaturation of ovalbumin. J. Agric. Food Chem. 36: 1156-1159
144. Ismail A. A., Manisch H. H. and Wong P. T. (1992) Aggregation of chymotrypsinogen: portrait by infrared spectroscopy. Biochim. Biophys. Acta 1121: 183-188
145. Konno T., Murata K. and Nagayama K. (1999) Amyloid-like aggregates of a plant protein: a case of a sweet-tasting protein, monellin. FEBS Lett. 454: 122-126
146. Srisailam S., Wang H. M., Kumar T. K., Rajalingam D., Sivaraja V, Sheu H. S. et al. (2002) Amyloid-like fibril formation in an all beta-barrel protein involves the formation of partially structured intermediate(s). J. Biol. Chem. 277: 19027-19036
147. Lundberg K. M., Stenland C. J., Cohen F. E., Prusiner S. B. and Millhauser G. L. (1997) Kinetics and mechanism of amyloid formation by the prion protein H1 peptide as determined by time-dependent ESR. Chem. Biol. 4: 345-355
148. Xiong L. W., Raymond L. D., Hayes S. F., Raymond G. J. and Caughey B. (2001) Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein. J. Neurochem. 79: 669-678
149. Kim Y. S., Randolph T. W., Stevens F. J. and Carpenter J. F. (2002) Kinetics and energetics of assembly, nucleation and growth of aggregates and fibrils for an amyloidogenic protein. Insights into transition states from pressure, temperature and co-solute studies. J. Biol. Chem. 277: 27240-27246
150. Nettleton E. J., Tito P., Sunde M., Bouchard M., Dobson C. M. and Robinson C. V. (2000) Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys. J. 79: 1053-1065
151. Pham T. N., Koide A. and Koide S. (1998) A stable single-layer beta-sheet without a hydrophobic core. Nat. Struct. Biol. 5: 115-119
152. Ohnishi S., Koide A. and Koide S. (2001) The roles of turn formation and cross-strand interactions in fibrillization of peptides derived from the OspA single-layer beta-sheet. Protein Sci. 10: 2083-2092
153. Goers J., Permyakov S. E., Permyakov E. A., Uversky V. N. and Fink A. L. (2002) Conformational prerequisites for alpha-lactalbumin fibrillation. Biochemistry 41: 12546-12551
154. Ventura S., Lacroix E. and Serrano L. (2002) Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils. J. Mol. Biol. 322: 1147-1158
155. Neri D., Billeter M., Wider G. and Wuthrich K. (1992) NMR determination of residual structure in a urea-denatured protein, the 434-repressor. Science 257: 1559-1563
156. Saab-Rincon G., Froebe C. L. and Matthews C. R. (1993) Urea-induced unfolding of the alpha subunit of tryptophan synthase: one-dimensional proton NMR evidence for residual structure near histidine-92 at high denaturant concentration. Biochemistry 32: 13981-13990
157. Buck M., Radford S. E. and Dobson C. M. (1994) Amide hydrogen exchange in a highly denatured state. Hen egg-white lysozyme in urea. J. Mol. Biol. 237: 247-254
158. Wang Y. and Shortle D. (1995) The equilibrium folding pathway of staphylococcal nuclease: identification of the most stable chain-chain interactions by NMR and CD spectroscopy. Biochemistry 34: 15895-15905
159. Kuhlman B., Luisi D. L., Young P. and Raleigh D. P. (1999) pKa values and the pH dependent stability of the N-terminal domain of L9 as probes of electrostatic interactions in the denatured state. Differentiation between local and nonlocal interactions. Biochemistry 38: 4896-4903
160. Jamin N., Coic Y. M., Landon C., Ovtracht L., Baleux F., Neumann J. M. et al. (2002) Most of the structural elements of the globular domain of murine prion protein form fibrils with predominant beta-sheet structure. FEBS Lett. 529: 256-260
161. Pappu R. V, Srinivasan R. and Rose G. D. (2000) The Flory isolated-pair hypothesis is not valid for polypeptide chains: implications for protein folding. Proc. Natl. Acad. Sci. USA 97: 12565-12570
162. Zagrovic B., Snow C. D., Khaliq S., Shirts M. R. and Pande V. S. (2002) Native-like mean structure in the unfolded ensemble of small proteins. J. Mol. Biol. 323: 153-164
163. Shortle D. and Ackerman M. S. (2001 ) Persistence of native-like topology in a denatured protein in 8 M urea. Science 293: 487-489
164. Ackerman M. S. and Shortle D. (2002) Robustness of the long-range structure in denatured staphylococcal nuclease to changes in amino acid sequence. Biochemistry 41: 13791-13797
165. Peti W., Smith L. J., Redfield C. and Schwalbe H. (2001) Chemical shifts in denatured proteins: resonance assignments for denatured ubiquitin and comparisons with other denatured proteins. J. Biomol. NMR 19: 153-165
166. Ohnishi S. and Shortle D. (2003) Observation of residual dipolar couplings in short peptides. Proteins 50: 546-551
167. Wong K. B., Clarke J., Bond C. J., Neira J. L., Freund S. M., Fersht A. R. et al. (2000) Towards a complete description of the structural and dynamic properties of the denatured state of barnase and the role of residual structure in folding. J. Mol. Biol. 296: 1257-1282
168. Ohnishi S. and Shortle D. (2003) Effects of denaturants and substitutions of hydrophobic residues on backbone dynamics of denatured staphylococcal nuclease. Protein Sci. 12: 1530-1537
169. Miyata T., Taneda S., Kawai R., Ueda Y., Horiuchi S., Hara M. et al. (1996) Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc. Natl. Acad. Sci. USA 93: 2353-2358
170. Antzutkin O. N., Leapman R. D., Balbach J. J. and Tycko R. (2002) Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry 41: 15436-15450
171. Antzutkin O. N., Balbach J. J. and Tycko R. (2003) Site-specific identification of non-beta-srrand conformations in Alzheimer's beta-amyloid fibrils by solid-state NMR. Biophys. J. 84: 3326-3335